Pharmaceuticals Tender

Pharmaceuticals Tender

Proprietary pharmaceuticals to the North East Purchasing Group.

UK-Reading: Various medicinal products

2013/S 007-007672

Contract notice

Supplies

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Commercial Medicines Unit
Premier House, 60 Caversham Road
Contact point(s): via CMU Bravosolution website
For the attention of: Sarah Blackman
RG1 7EB Reading
UNITED KINGDOM

Internet address(es):

General address of the contracting authority: https://cmu.bravosolution.co.uk

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local sub-divisions
I.3)Main activity
Health
Other: Public Procurement
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:
Proprietary pharmaceuticals to the North East Purchasing Group
II.1.2)Type of contract and location of works, place of delivery or of performance
Supplies
Purchase
Main site or location of works, place of delivery or of performance: The framework agreement is intended for use by the Department of Health and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Documents 10a and 10b in the ITT Documents for the list of Purchasing Points.
NUTS code UK
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves the establishment of a framework agreement
II.1.4)Information on framework agreement

Duration of the framework agreement

Duration in months: 24
Justification for a framework agreement, the duration of which exceeds four years: NE – 1.7.2013 to 30.6.2015 – Plus options to extend for up to a further 24 months.
All regions – Elvitegravir / Cobicistat / Emtricitabine / Tenofovir 150MG/150MG/200MG/300MG Tablets – 1.7.2013 to various end dates.
The total maximum duration of the framework agreement will be no more than 48 months.
Estimated total value of purchases for the entire duration of the framework agreement

Estimated value excluding VAT: 140 000 000 GBP

II.1.5)Short description of the contract or purchase(s)
Proprietary pharmaceuticals to the North East Purchasing Group (Documents 10a and 10b of the ITT Pack)
1.7.2013 to 30.6.2015 – with options to extend for a further 24 months.
II.1.6)Common procurement vocabulary (CPV)

33690000, 33693000, 85149000

II.1.7)Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): yes
II.1.8)Lots
II.1.9)Information about variants
Variants will be accepted: yes
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:
Please see Document No. 6a, 6b , 6c and 6d of the ITT Pack for product listing and usage.
II.2.2)Information about options
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion
Duration in months: 24 (from the award of the contract)

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
Parent company or other guarantees may be required in certain circumstances.
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
Refer to the Price and Payment clauses contained within the ITT, Document No. 3 Conditions of Contract.
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
No special legal form is required but, if a contract is awarded to a consortium of economic operators, the members of that consortium may be required to form a legal entity before entering into a Framework Agreement and may be required to provide parent company or directors’ guarantees or, if not required to form a legal entity, members of a consortium may be required to accept joint and several liability both to the Contracting Authority under the Framework Agreement and to other contracting authorities awarding contracts under the Framework Agreement.
III.1.4)Other particular conditions
The performance of the contract is subject to particular conditions: yes
Description of particular conditions: Refer to the ITT, Document No. 3 Conditions of Contract.
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
Information and formalities necessary for evaluating if the requirements are met: Please refer to the award criteria contained in the ITT.
III.2.3)Technical capacity
Information and formalities necessary for evaluating if the requirements are met:
Please refer to the award criteria contained in the ITT.
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure
Open
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria
The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
IV.2.2)Information about electronic auction
An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:
CM/PHR/11/5300.
IV.3.2)Previous publication(s) concerning the same contract
no
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
22.2.2013 – 12:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence
VI.2)Information about European Union funds
VI.3)Additional information
Any supplier may be disqualified who does not respond to the following in the requisite manner:
1) Submission of expression of interest and procurement specific information.
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk

Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:

— accept the terms and conditions and click continue,
— enter your correct business and user details,
— note the username you chose and click “Save” when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select “Response to ITT”;
c. select “ITTs Open To All Suppliers”;
d. access listing related to this procurement Proprietary pharmaceuticals to the itt_29471 North East Purchasing Group and view details;
e. click on “Express interest” button at the top of the page.
f. Once you have expressed interest, the ITT will move to “My ITTs”, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the “Publish” button.
1.3) For any support in registering on the portal or submiting your expression of interest please contact the eTendering Help-desk at +44 8003684850 or help@bravosolution.co.uk

2) Entering general supplier information.
To manage and assess supplier information the Contracting Authority requests candidates provide their supplier profile in the NHS Supplier Information Database (sid4health) as follows:
2.1) Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4health. This normally is provided within 48 hours but may take up to 5 days (turnaround times will vary from country to country), so please ensure this step is completed as soon as possible. The D-U-N-S® number is the standard supplier coding for the NHS and must be obtained for use in all trading with the NHS. Check to see if your company has a D-U-N-S® Number on the Sid4health registration page.
2.2) Candidates must go to the following web page http://www.sid4health.nhs.uk/home.action and select the Register Supplier Organisation on the left of the page. Key in details as shown to search for your D-U-N-S® Number. If you are not on their database click on the link at the bottom of the page to obtain a number from D&B.

2.3) Once registration has been authorised by the sid4health administrator and after receiving logon details, access the Profile Management area and create and validate your sid4health company profile. (Candidates must publish at least one validated profile to make their profile available for buyers to view generally – see the Help page on sid4health within Profile Management for more details).
2.4) Candidates should ensure all the mandatory fields of their sid4health profile are completed. Failure to comply with the completion of all mandatory fields could result in the elimination from the procurement process at this stage. D&B data will be supplied automatically by D&B.
2.5) Once a candidate has ensured that all the required fields are completed and the profile has been validated. They must add the profile to the Request to Participate list ID number T1200-299] and named Proprietary pharmaceuticals to the North East Purchasing Group Select ‘View all request to participate lists’ on the left menu and search/select this list. Select the Join button to the right of the list and then select the validated profile to allocate to this procurement (you may have more than one validated profile as you may have different information held against your profile for different procurements)
2.6) Where access to sid4health is unavailable, please contact the sid4health Helpdesk at: helpsid4health@eurodyn.com

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
Potential suppliers should note that, in accordance with the Government’s policies on transparency, the Contracting Authority intends to publish the OJEU, ITT and the text of final framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: http://www.cabinetoffice.gov.uk/resource-library/guidance-transparency

VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:8.1.2013

Enjoyed this post? Share it!